PhaseBio Pharmaceuticals, Inc. (PHAS)
Retained Earnings
-$419.60M
Quarterly · Period ending: · USD
PHAS Retained Earnings
Latest reported-$419.60Mperiod ending
Latest reported-$419.60Mperiod ending
PHAS Quarterly Retained Earnings (-$99.07M → -$419.60M)
Quarterly retained earnings
High-resolution chart · PNG
PHAS retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -419,600,000 | |
| -402,935,000 | |
| -391,794,000 | |
| -348,684,000 | |
| -316,760,000 | |
| -288,081,000 | |
| -260,723,000 | |
| -230,348,000 | |
| -205,205,000 | |
| -177,063,000 | |
| -162,158,000 | |
| -150,827,000 | |
| -139,436,000 | |
| -130,204,000 | |
| -122,911,000 | |
| -118,043,000 | |
| -110,142,000 | |
| -99,065,000 |